The document outlines the key topics covered in a course on communicable disease control. It begins with an introduction to communicable diseases and their classification. It then discusses the natural history of disease transmission, including the chain of transmission from infectious agents to susceptible hosts. The major principles of communicable disease control are described as attacking the source of infection, interrupting transmission routes, and protecting susceptible hosts. The document provides an overview of the scope of communicable diseases in Ethiopia and outlines some of the major terms and concepts covered in the course.
this power point slide consists the important points regarding to infectious diseases control, helps for medical students as well as clinicians to add some values on their level of awareness regarding to communicable diseases.
this power point slide consists the important points regarding to infectious diseases control, helps for medical students as well as clinicians to add some values on their level of awareness regarding to communicable diseases.
This PPT comprises of entire unit III ie. Introduction to epidemiology.
The content includes definition,aims,scope,uses of epidemiology, epidemiological triad, dynamics of disease transmission, measurement of mortality and morbidity, levels of prevention, epidemiological methods. incidence and prevalence, descriptive epidemiology, analytical epidemiology
Microbe-Human Interactions: Infection and DiseaseMELVIN FAILAGAO
Chapter 12 Microbe-Human Interactions: Infection and Disease
subtopics:
1. The progress of an infection
2. Epidemiology: The study of disease in Populations
3. Non specific host defenses
4. Defense mechanisms of the host in perspective
Travel-related infectious diseases on the rise
International travel has an important role in the transmission of emerging and re-emerging infectious diseases across geographical areas.
Since 1980, the world has been threatened by different waves of emerging disease epidemics.
In the twenty-first century, these diseases have become an increasing global concern because of their health and economic impacts in both developed and resource-constrained countries.
It is difficult to stop the occurrence of new pathogens in the future due to the interconnection among humans, animals, and the environment.
As many as 43%–79% of travelers to low- and middle-income countries become ill with a travel-related health problem.
Although most of these illnesses are mild, some travelers become sick enough to seek care from a health care provider.
This PPT comprises of entire unit III ie. Introduction to epidemiology.
The content includes definition,aims,scope,uses of epidemiology, epidemiological triad, dynamics of disease transmission, measurement of mortality and morbidity, levels of prevention, epidemiological methods. incidence and prevalence, descriptive epidemiology, analytical epidemiology
Microbe-Human Interactions: Infection and DiseaseMELVIN FAILAGAO
Chapter 12 Microbe-Human Interactions: Infection and Disease
subtopics:
1. The progress of an infection
2. Epidemiology: The study of disease in Populations
3. Non specific host defenses
4. Defense mechanisms of the host in perspective
Travel-related infectious diseases on the rise
International travel has an important role in the transmission of emerging and re-emerging infectious diseases across geographical areas.
Since 1980, the world has been threatened by different waves of emerging disease epidemics.
In the twenty-first century, these diseases have become an increasing global concern because of their health and economic impacts in both developed and resource-constrained countries.
It is difficult to stop the occurrence of new pathogens in the future due to the interconnection among humans, animals, and the environment.
As many as 43%–79% of travelers to low- and middle-income countries become ill with a travel-related health problem.
Although most of these illnesses are mild, some travelers become sick enough to seek care from a health care provider.
Similaire à 1.An introduction to communicable disease control (20)
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
3. Course outlines
• Introduction
• Scope of communicable Disease
• Why CDC
• Natural hx of disease
• Chain of Disease Transmission
• Principles of CDC
CDC bY Aschalew M 3
12/17/2023
4. • What is Disease?
• What do you think ‘Communicable Disease’ is?
CDC bY Aschalew M 4
12/17/2023
5. INTRODUCTION
• Diseases can be classified can be classified based on the time course
and cause.
• Based on time course
1.Acute (characterized by a rapid onset and a short duration),
2.Chronic disease (characterized by prolonged duration).
• Based on cause
1. infectious, (i.e. caused by living parasitic organisms such as viruses,
bacteria, parasitic worms, insects, etc.),
2.noninfectious (which are caused by something other than a living parasitic
organism).
CDC bY Aschalew M 5
12/17/2023
6. INTRODUCTION…
• However, most of the common diseases in Africa are environmental
diseases (infectious).
• These infectious diseases are called communicable diseases, because
they spread from person to person, or sometimes from animals to people.
CDC bY Aschalew M 6
12/17/2023
7. Why are we concerned about Communicable diseases
• Many of them are very common
• Some of them are serious and cause death and disability
• Some of them cause widespread out breaks of disease or epidemics
• Most of them are preventable by fairly simple means.
• Poor socio-economic status of the individuals makes them vulnerable
to a variety of diseases
• Low educational status
• Lack of access to modern health care service
CDC bY Aschalew M 7
12/17/2023
8. Scope of Communicable Diseases in Ethiopia.
• In the past 7 decades, there has been a dramatic fall in the incidence of
infectious diseases, due:
Immunization
Anti-microbial chemotherapy
Improved nutrition
Better sanitation and housing
CDC bY Aschalew M 8
12/17/2023
9. Scope of CDC…
• Ethiopia, as part of the developing world, has two big health problems.
These are:
• Infectious diseases (communicable diseases) 80% of these can be prevented
by simple sanitary measures.
• Nutritional problems
CDC bY Aschalew M 9
12/17/2023
10. Table 1.1 Top 10 leading causes of outpatient visits in most regions of Ethiopia,
September 2008–August 2009. (From: Federal Ministry of Health (2010) Health
and Health Related Indicators: 2008/9, Addis Ababa, Ethiopia)
CDC bY Aschalew M 10
12/17/2023
11. The top leading causes of deaths
• Tuberculosis of the respiratory system (10.1%)
• Pneumonia (7.3%) –
• All types of malaria (4.6%)
• Bacillary dysentery (2.2%)
• Meningitis (1.5%)
• Gastroenteritis and colitis (1.1%)
• AIDS (0.8%) –
• Leishmaniasis (0.5%
CDC bY Aschalew M 11
12/17/2023
13. Term Definitions
• Epidemiology- the study of the frequency, distribution and determinants
of disease and other health related conditions in human populations, and the
application of this study to the promotion of health and to the prevention
and control of health problems.
• "Frequency" shows that “epidemiology” is a quantitative science (e.g.
occurrence of illness is measured using morbidity rates).
• Distribution" refers to the occurrence of disease by place, person and
time.
• "Determinants” These are factors that determine whether or not a
person will get a disease.
CDC bY Aschalew M 13
12/17/2023
14. Definitions of Terms…
• Epidemics - the occurrence of any health related condition in a given
population in excess of the usual frequency in that population.
• Endemic - a disease that is usually present in a population or in an area at a
more or less stable level.
• Sporadic - a disease that does not occur in that population, except at
occasional and irregular intervals.
• Pandemic - an epidemic disease which occurs worldwide.
• Infestation – presence of living infectious agent on the exterior surface of
the body
CDC bY Aschalew M 14
12/17/2023
15. Natural History of Disease
• Natural History of Disease: is the course of disease over time
without/unaffected by treatment or intervention
They have four phases
1. Stage of susceptibility: Period of exposure
2. Stage of subclinical disease (Pre-symptomatic stage)
3. Stage of clinical disease
4. Stage of outcome
NB: recovery will be at any stage in the course of
infection
15
CDC bY Aschalew M
12/17/2023
16. Course of Disease over time
• It begins with an exposure of a susceptible host to a causative
agent.
• Each disease has its own natural history
16
Recovery is possible
Pathological Onset of Symptoms Usual time of Diagnosis
Changes
Exposure
Stage of Stage of Stage of Clinical Stage of outcome: Time
Susceptibility Subclinical Disease Disease Disease or
(Pre-symptomatic disease) (Symptomatic Stage)| Recovery or
Death
CDC bY Aschalew M
12/17/2023
17. Course of disease over time…
1.Stage of susceptibility
• Disease has not yet developed but risk factors are present
Ex. Unprotected sex practitioner is susceptible to HIV.
2. Stage of pre-symptomatic disease (Sub-clinical stage)
• The disease process has already begun but not manifested i.e. no signs and symptoms
of disease are detectable
• The disease can only be detected through special tests.
Example:
• Detection of antibodies against HIV in an apparently healthy person
• Ova of intestinal parasite in the stool of apparently healthy children
17
CDC bY Aschalew M
12/17/2023
18. Course of disease over time …
3. The Clinical Stage
Signs and symptoms of the disease are manifested in this stage
Clinical stage of different diseases differs in duration, severity, disability and
death.
4. Stage of Outcome
In this stage the clinical disease results in one of the following:
• Impairment: symptoms at organ level ,e.g. broken leg
• Disability: objective alteration of behavior or performance at individual
level e.g. can’t work
• Handicap: changed interaction with others at social or environmental
level.
• Death
18
CDC bY Aschalew M
12/17/2023
19. Chain model of infectious diseases
Susceptible
host
Causative
agent
Reservoir
Portal of
entry Mode of
transmission
Portal of
exit
19
CDC bY Aschalew M
12/17/2023
20. Chain of Transmission…
1.Infectious agent: An organism that is capable of producing infection
or infectious disease.
• Etiological agents are generally classified into:
• Metazoan (multicellular organisms). (e.g. Helminths).
• Protozoa (Unicellular organisms) (e.g. Ameobae)
• Bacteria (e.g. Treponema pallidum, Mycobacterium tuberculosis, etc.)
• Fungus (e.g. Candida albicans)
• Virus (e.g. Chickenpox, polio, etc.)
CDC bY Aschalew M 20
12/17/2023
21. Chain of Transmission…
2.Reservoir of infection: Any person, animal, arthropod, plant, soil or
substance (or combination of these) in which an infectious agent
normally lives and multiplies.
CDC bY Aschalew M 21
12/17/2023
22. Types of reservoirs
a. Man:
• There are a number of important pathogens that are specifically adapted to man
like sexually transmitted diseases, measles, mumps, etc.
b. Animals:
Some infective agents that affect man have their reservoir in animals. The term
“zoonosis” is applied to disease transmission from animals to man.
e.g
• Bovine tuberculosis - cow to man
• Brucellosis - Cows, pigs and goats to man
• Anthrax - Cattle, sheep, goats, horses to man
• Rabies - Dogs, foxes and other wild animals to man
CDC bY Aschalew M 22
12/17/2023
23. Reservoirs…
c. Non-living things as reservoir:
• Many of the agents are basically saprophytes living in soil and fully
adapted to live freely in nature.
E.g. Clostridium botulinum etiologic agent of Botulism
Clostridium tetani etiologic agent of Tetanus
Clostridium welchi etiologic agent of gas gangrene
CDC bY Aschalew M 23
12/17/2023
24. Chain of Transmission…
3. Portal of exit
• This is the site through which the agent escapes from the reservoir. Examples
include:
GIT: typhoid fever, bacillary dysentery, amoebic dysentery, cholera,
ascariasis, etc.
Respiratory: tuberculosis, common cold, etc.
Skin and mucus membranes: Syphilis
CDC bY Aschalew M 24
12/17/2023
25. Chain of Transmission…
4. Mode of transmission: Refers to the mechanisms by which an
infectious agent is transferred from one.
Transmission may be direct or indirect.
CDC bY Aschalew M 25
12/17/2023
26. 1. Direct transmission
• Consists of essentially immediate transfer of infectious agents from an
infected host or reservoir to an appropriate portal of entry.
Through:- touching, biting, kissing, sexual intercourse, mother to child.
a. Direct Vertical
e.g Transplacental transmission of syphilis, HIV, etc. b. Direct
horizontal.
b. Direct horizontal
Direct touching, biting, kissing, sexual intercourse, droplet spread onto
the conjunctiva or onto mucus membrane of eye, nose or mouth during
sneezing coughing
CDC bY Aschalew M 26
12/17/2023
27. 2.Indirect transmission
a. Vehicle-borne transmission: Indirect contact through contaminated
inanimate objects (fomites) like:
- cooking or eating utensils, surgical instruments.
- Contaminated food and water
- Biological products like blood, serum, plasma or IV-fluids
b. Vector-borne transmission: Occurs when the infectious agent is
conveyed by an arthropod (insect) to a susceptible host.
CDC bY Aschalew M 27
12/17/2023
28. Types of Vector-borne transmission…
i. Mechanical transmission: The arthropod transports the agent by
soiling its feet or proboscis, in which case multiplication of the
agent in the vector does not occur. (e.g. common house fly.)
ii. Biological transmission: This is when the agent multiplies in the
arthropod before it is transmitted, such as the transmission of
malaria by mosquito.
CDC bY Aschalew M 28
12/17/2023
29. Indirect transmission…
C. Air-borne transmission
• Dissemination of microbial agent by air to a suitable portal of entry,
usually the respiratory tract.
CDC bY Aschalew M 29
12/17/2023
30. Chain of Transmission…
5.Portal of entry:The site in which the infectious agent enters to the
susceptible host. For example:
• Mucus membrane
• Skin
• Respiratory
• GIT
• Blood tract
CDC bY Aschalew M 30
12/17/2023
31. Chain of Transmission…
6. Susceptible host (host factors):
• A person or animal lacking sufficient resistance to a particular
pathogenic agent to prevent disease if or when exposed.
• Occurrence of infection and its outcome are in part determined by
host factors.
CDC bY Aschalew M 31
12/17/2023
32. Carrier
• Carrier: is an infected person or animal that does not have a
clinical sign /symptom of the disease but serves as a potential
source of infection to other.
• Unaware of their condition known by bacteriological/lab.
Four different types carrier
• Healthy/Asymptomatic carriers: Infection remain unapparent.
no sign symptom suggestive of clinical disease. ex. polio virus,
hepatitis
• Incubatory/precocious carriers: Excrete the pathogen during
incubation periods, before onset of symptom or sign
• Convalescent carrier: Continue to harbor pathogen after
recovering from the illness. Ex. diphtheria from time of recovery
to when shedding stops.
• Chronic carriers: Carriers state persists for long period of time.
32
CDC bY Aschalew M
12/17/2023
33. Time Course of Infectious Diseases
Different periods are encountered in the course of development of infectious
disease. Those periods are described below:
1. Pre-patent Period
• Is the time interval between infection and the point at which the infection
can first be detected
• Measured by the first shedding of the infectious agent by the host.
• Sometimes infection cannot be detected when the agent is first shed, only
later when antibodies to the agent appear, as in HIV
2. Incubation Period
• The time interval between infection and the first clinical manifestation of
disease.
33
CDC bY Aschalew M
12/17/2023
34. Time course…
3. Prodromal period
• The time interval between the onset of symptoms of an
infectious disease and the appearance of characteristic
manifestations.
Ex. In measles from the onset of fever and coryza to the
development of characteristic signs like koplick spots and
characteristic skin lesions.
4. Communicable Period
• The period during which an infected host can transmit the
infection to others
• Measured by the length of the time in which the agent is shed
by the host
• Degree of transmissibility does not remain constant throughout
the period of communicability, as the amount of infectious
agent that is shed by the infected host is variable at different
points time
34
CDC bY Aschalew M
12/17/2023
35. Time course…
5. Generation time
• Is the period between the onset of infection in a host and the
maximal communicability of that host
• Maximal communicability may be during or after the
incubation period.
6. Latent Period
• The time interval between recovery and the occurrence of a
relapse or recrudescence of infectious disease
35
CDC bY Aschalew M
12/17/2023
36. Principles of Communicable Disease Control
• The actions may be effected through:
A. Attacking the source
B. Interrupting the mode of transmission and
C. Protecting the host (susceptibility)
A. Attacking the source
Domestic animals as reservoirs
• Immunization ex. Brucellosis
• Destruction of infected animals ex. Rabies
Humans as reservoirs
• Isolation of infected persons & separation of infected
persons from other for the period of communicability.
36
CDC bY Aschalew M
12/17/2023
37. Principles of Communicable Disease Control…
Treatment of cases (clinical) and carriers
• Mass treatment – where large proportion are known to have a
disease it is sometimes advisable to treat everybody, without
checking whether individuals have disease or not.
Ex. Cholera epidemic
Quarantine – the limitation of freedom of movement of
apparently healthy persons or animals who have been exposed to
a case or infections disease.
• Cholera, plaque, and yellow fever are the 3 internationally
quarantinable diseases.
37
CDC bY Aschalew M
12/17/2023
38. Principles of Communicable Disease Control…
B. Interrupting transmission
For Transmission by in gestation
Purification of water
Pasteurization of milk
Inspection procedures designed to ensure safe food supply
Improve housing conditions
For Transmission by in halation
Chemical disinfections of air
Improving ventilation
For transmission by vector or intermediate hosts
• Vector control measures
• Environmental manipulation
38
CDC bY Aschalew M
12/17/2023
39. Principles of Communicable Disease Control…
C. Measures that protect host
Immunization
• Active immunization – when either the altered organism
or its products is given to a person to induce production of
antibodies. Ex. BCG
• Passive immunization – provision of ready – made
antibodies. Ex. TAT
Chemoprophylaxis:
• Use of antibiotics for known contacts to a case
Ex. Ciprofloxacin for contacts to a case of M. meningitis
Better Nutrition
• Malnourished children get infections more easily & suffer
more severe complications
39
CDC bY Aschalew M
12/17/2023
40. Principles of Communicable Disease Control…
NB:
Effective control of disease is most likely when a
combination of methods
attacking the source,
interrupting transmission, and
protecting the host
is used at the same.
40
CDC bY Aschalew M
12/17/2023